Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
RS Hogg, KV Heath, B Yip, KJP Craib… - Jama, 1998 - jamanetwork.com
Context.—Clinical trials have established the efficacy of antiretroviral therapy with double-
and triple-drug regimens for individuals infected with the human immunodeficiency virus (HIV)…
and triple-drug regimens for individuals infected with the human immunodeficiency virus (HIV)…
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy
ContextCurrent recommendations for initiation of antiretroviral therapy in patients infected
with human immunodeficiency virus type 1 (HIV) are based on CD4 T-lymphocyte cell counts …
with human immunodeficiency virus type 1 (HIV) are based on CD4 T-lymphocyte cell counts …
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based …
JSG Montaner, VD Lima, R Barrios, B Yip, E Wood… - The Lancet, 2010 - thelancet.com
Background Results of cohort studies and mathematical models have suggested that
increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV …
increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV …
Barriers to use of free antiretroviral therapy in injection drug users
SA Strathdee, A Palepu, PGA Cornelisse, B Yip… - Jama, 1998 - jamanetwork.com
Context.—In British Columbia, human immunodeficiency virus (HIV)–infected persons eligible
for antiretroviral therapy may receive it free but the extent to which HIV-infected injection …
for antiretroviral therapy may receive it free but the extent to which HIV-infected injection …
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy
…, RS Hogg, WWY Dong, B Yip… - The Journal of …, 2005 - academic.oup.com
Objective. The objective of this study was to systematically characterize the incidence and
determinants of antiretroviral resistance in the HOMER (Highly Active Antiretroviral Therapy […
determinants of antiretroviral resistance in the HOMER (Highly Active Antiretroviral Therapy […
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
RS Hogg, K Heath, D Bangsberg, B Yip, N Press… - Aids, 2002 - journals.lww.com
Results As of 30 September 2000, 106 subjects had died. Cumulative mortality was 3.9%(±0.5%)
at 12 months. In a multivariate model, after controlling for other variables that were …
at 12 months. In a multivariate model, after controlling for other variables that were …
Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 …
E Wood, RS Hogg, B Yip, PR Harrigan… - Annals of internal …, 2003 - acpjournals.org
Background: The safety of delaying highly active antiretroviral therapy (HAART) in HIV-infected
patients is uncertain when the CD4+ cell count declines below 0.350 × 10 9 cells/L. …
patients is uncertain when the CD4+ cell count declines below 0.350 × 10 9 cells/L. …
[HTML][HTML] Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as …
…, VD Lima, PR Harrigan, L Lourenço, B Yip… - PloS one, 2014 - journals.plos.org
Background There has been renewed call for the global expansion of highly active antiretroviral
therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, …
therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, …
Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens
RS Hogg, B Yip, C Kully, KJP Craib… - Cmaj, 1999 - Can Med Assoc
BACKGROUND: The efficacy of triple-drug antiretroviral regimens in the treatment of patients
infected with HIV has been established in several randomized clinical trials. However, the …
infected with HIV has been established in several randomized clinical trials. However, the …
The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time
…, DR Bangsberg, RS Hogg, R Gross, B Yip… - JAIDS Journal of …, 2009 - journals.lww.com
Objective: To characterize the impact of longitudinal adherence on survival in drug-naive
individuals starting currently recommended highly active antiretroviral therapy (HAART) …
individuals starting currently recommended highly active antiretroviral therapy (HAART) …
